Vivani Medical, Inc. Warrants expiring 03/14/2024
VANIW
VANIW was delisted on the 8th of September, 2022.
5 hedge funds and large institutions have $74K invested in Vivani Medical, Inc. Warrants expiring 03/14/2024 in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
25% more funds holding
Funds holding: 4 → 5 (+1)
16% less capital invested
Capital invested by funds: $88K → $74K (-$14K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.58K |
Top Sellers
VANIW Hedge Fund Activity: Q3 2021 in Review
5 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) for Q3 2021, worth a combined $74K — down 16% from $88K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new VANIW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $16.5K.
- 5 institutional investors held Vivani Medical, Inc. Warrants expiring 03/14/2024 (VANIW) as of Q3 2021, up from 4 in Q2 2021.
- Funds reported $74K of Vivani Medical, Inc. Warrants expiring 03/14/2024 stock for Q3 2021, down 16% quarter-over-quarter.
- 1 fund opened new Vivani Medical, Inc. Warrants expiring 03/14/2024 positions in Q3 2021 and 0 closed out, a net change of +1 holder.
- The largest Vivani Medical, Inc. Warrants expiring 03/14/2024 buyer in Q3 2021 was Susquehanna International Group, an estimated $16.5K added.
Based on aggregated 13F filings for Q3 2021.